MSB 2.51% 97.0¢ mesoblast limited

these "falls", page-2

  1. 1,363 Posts.
    lightbulb Created with Sketch. 116
    Ang, i dont disagree with your frustration and lack of comms from the company, But it is JCR that is lodging, get onto there website, you will see that they are at lodgement stage with this product, we are talking about health care here, this is not lodging registration for your car. This could take 6 mths. the regulators will need to sift through all the medical evidence etc..., Lodgement does not mean approval.

    I'm more frustrated with the lack of news on:

    1. Spinal

    2 Heart recruitment

    3. Diabetes

    4. Arthritis

    My personal view is that we will get re-rated on Japan approval.

    Why you ask, because all of our trials a based on one platform, so efficacy is acheived in one likely to be acheived in others which means we are well on our way.

    But dont get me wrong, i'm bloody frustrated just like you.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.